Venom allergy

This study is testing an allergy immunotherapy called Beltaven for people allergic to bee or wasp stings. Researchers want to see if a 3-week series of shots helps patients tolerate stings without a severe reaction. The study will follow 27 participants aged 14 and older who have…

This study tests whether a blood test called BAT inhibition can replace live insect sting challenges for people with wasp venom allergy. Currently, sting challenges are the only reliable way to see if venom immunotherapy is working, but they are not widely available. Researchers …

Beekeepers get stung often, and many develop antibodies to bee venom. Only a few have severe allergic reactions. This study compares blood and skin test results from beekeepers who tolerate stings, beekeepers who are allergic, and people who are not beekeepers. Researchers aim to…

This study aims to develop a blood test that measures B regulatory cells, which may indicate whether allergen immunotherapy (allergy shots) is successfully reducing allergic reactions. Researchers will study 80 adults with pollen or venom allergies who are starting routine allerg…

This study looks at how well venom immunotherapy protects people with Jack Jumper ant allergy years after treatment stops. About 100 adults who completed 3-6 years of therapy and have been off treatment for at least 18 months will have a supervised sting challenge and blood test.…

This study looks at different forms of IgE (a protein involved in allergic reactions) in healthy volunteers and people with conditions like severe allergies, chronic hives, mastocytosis, and immune deficiencies. Researchers aim to understand how these IgE variations relate to hea…

This study is investigating why bee venom immunotherapy (VIT) doesn't work for some people. Researchers will test blood samples from 266 adults with bee venom allergy before they start treatment. They want to see if having a strong allergic response to a specific bee venom compon…